Videobot

Finland · www.videobot.com · 14 vendors

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 14 sub-vendors.

Insights

Last updated 2026-08-16 · revision 1

14 direct vendors, 199 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 5/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Videobot's migration readiness is moderate, with significant areas of uncertainty. The company's tech stack includes modern elements like Agentic AI and HLS video streaming, suggesting a foundation that could adapt to cloud environments. Its strong focus on SOC 2 and GDPR compliance means it has established processes for data governance and security, which is beneficial for managing compliance during migration. However, several critical factors remain unknown. There is no data on financial stability (revenue concentration, growth history), which is crucial for assessing the ability to fund a potentially costly migration. Data residency requirements are not specified, which could introduce significant complexities, especially given their use of "European Data Centres." Furthermore, while vendor geographic diversity is present across 5 countries for 14 services, the actual number of distinct vendors, their contract complexity, and the overall "Vendor Lock-in Risk" are unknown. This lack of clarity on vendor relationships and potential lock-in, combined with unspecified data residency and financial capacity, presents considerable challenges and risks for a smooth migration.

Compliance

10 in-scope frameworks identified; showing 3.

ISAE 3000 (source) — Assessment Required

ISAE 3000 (International Standard on Assurance Engagements) is relevant for organisations that provide assurance reports on non-financial information, or for service organisations that undergo third-party assurance engagements. Videobot's SOC 2 Type II audit is itself conducted under ISAE 3402/SSAE 18 standards (the international/US equivalents for service organisation controls), which are closely related to ISAE 3000. However, no standalone ISAE 3000 assurance report was found. Risk is Low because: (1) ISAE 3000 is not a mandatory regulatory requirement for Videobot's industry; (2) SOC 2 Type II provides equivalent or superior assurance for enterprise clients; (3) ISAE 3000 is more commonly required for financial services or audit firms. The framework is not directly applicable to Videobot's core business as a video engagement SaaS platform, unless specific enterprise clients or pharmaceutical industry contracts require it.

Evidence: https://www.videobot.com, https://trust.videobot.com, https://www.iaasb.org/publications/international-standard-assurance-engagements-isae-3000-revised-assurance-engagements-other-audits

TCF — Compliant

Videobot publishes a TCF Attestation on its website, indicating formal participation in or compliance with the IAB Europe Transparency and Consent Framework. The TCF is relevant for digital advertising and consent management in the EU. Videobot's platform, which embeds on customer websites and collects interaction data, requires robust consent management. The TCF Attestation demonstrates that Videobot has formally documented its role and data processing activities within the TCF framework. Risk is Low because: (1) the TCF Attestation is publicly available; (2) the platform is described as not using traditional cookies or local storage for user identification; (3) GDPR-aligned consent management is documented. The main residual risk is ongoing compliance with IAB Europe's evolving TCF requirements following the Belgian DPA's 2022 ruling on TCF.

Evidence: https://www.videobot.com/tcf-attestation, https://www.videobot.com, https://iabeurope.eu/tcf-2-0/

EU Pharmaceutical Regulations — Assessment Required

Videobot is explicitly positioned as a platform for the pharmaceutical industry, serving HCPs, patients, and pharmaceutical companies (Boehringer Ingelheim, Alfasigma). The pharmaceutical sector is one of the most heavily regulated industries in the EU. Key applicable frameworks include: (1) EudraLex Volume 4 (GxP — Good Practice guidelines) for computerised systems used in pharmaceutical manufacturing and clinical contexts; (2) EFPIA (European Federation of Pharmaceutical Industries and Associations) digital engagement guidelines for HCP interactions; (3) EU Regulation 536/2014 on clinical trials if any trial-related data is processed; (4) PMCPA/EFPIA codes on digital promotion to HCPs. Risk is High because: (1) pharmaceutical companies using Videobot for HCP engagement and patient adherence are subject to strict promotional and data integrity regulations; (2) as a technology vendor to pharma, Videobot may be subject to GxP computerised system validation requirements (CSV/CSA); (3) non-compliance could result in regulatory action against Videobot's pharmaceutical clients, creating significant commercial and reputational risk; (4) the Veeva integration (official partnership) places Videobot within regulated pharmaceutical commercial operations workflows.

Evidence: https://www.videobot.com, https://www.ema.europa.eu/en/human-regulatory-overview/research-development/scientific-guidelines/good-manufacturing-practice/eudralex-volume-4-good-manufacturing-practice-medicinal-products-human-veterinary-use, https://www.efpia.eu/relationships-code/, https://www.fimea.fi/en_GB/web/en/-/medicines-act

Financials

Financial Resilience Score: 5/10

Videobot Oy is a small private Finnish SaaS company for which no quantitative financial data (revenue, EBIT, equity) could be retrieved in this research session. Financial resilience must therefore be assessed qualitatively based on public web presence and market positioning. The company shows several positive signals: enterprise-grade compliance certifications (SOC 2 Type I & II, GDPR alignment, European data hosting), a blue-chip customer reference list spanning pharma (Boehringer Ingelheim, Alfasigma), telco (Telia, Vodafone, Orange), and consumer brands (Toyota, Verisure, Sprite), and a strategic pivot toward the high-value pharmaceutical HCP engagement vertical with a Veeva integration providing some competitive moat. However, meaningful risks temper this assessment. As a small private SaaS still scaling, profitability and cash runway are unknown. The recent repositioning from a horizontal interactive-video widget to a pharma-focused agentic platform could indicate either promising vertical focus or churn/traction issues in the original market. The interactive video engagement space is highly competitive (Wistia, Vidyard, Mindstamp, Tolstoy/Firework, HeyGen). Marquee customer logos may represent pilots rather than large recurring contracts, and there is dependency on a small founding/leadership team. Without access to PRH Virre filings, a mid-range score reflects the balance of qualitative strengths against unverifiable financial fundamentals.

Key strengths: SOC 2 Type I & II certified and GDPR-aligned with European data hosting, Blue-chip customer references across pharma, telco, and consumer brands, Strategic focus on high-value pharmaceutical HCP engagement vertical, Veeva integration provides moat in life-sciences MarTech, Two-country footprint (Finland + Luxembourg) indicates early internationalisation, Platform reach claimed in 25+ countries with 250k+ monthly interactions

Risk factors: Small private SaaS; profitability and cash runway unknown without filings, Product repositioning from horizontal to pharma-focused platform may signal traction issues, Highly competitive interactive video engagement space, Customer concentration risk — marquee logos may be pilots rather than recurring contracts, Dependency on a small founding/leadership team, No public disclosure of revenue, EBIT, equity, or headcount

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report